L N Maslov Selected Research

DuP 734

11/2000	[Anti-arrhythmic effect of the sigma-receptor blocker DuP 734 in ischemia and myocardial reperfusion].
9/2000	[The use of delta-receptor antagonist DuP 734 for correction of the contractile diastolic cardiac dysfunction in reperfusion injury and oxidative stress].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

L N Maslov Research Topics

Disease

75	Ischemia 03/2024 - 02/2000
40	Infarction (Infarctions) 03/2024 - 01/2001
27	Hypoxia (Hypoxemia) 02/2024 - 01/2003
19	Coronary Occlusion 01/2024 - 06/2001
19	Reperfusion Injury 01/2021 - 02/2000
11	Myocardial Infarction 12/2020 - 02/2002
8	Ventricular Fibrillation 01/2006 - 01/2001
8	Cardiac Arrhythmias (Arrythmia) 11/2004 - 03/2000
5	Necrosis 12/2020 - 02/2002
5	Hypertrophy 01/2016 - 08/2012
4	Metabolic Syndrome (Dysmetabolic Syndrome X) 04/2023 - 01/2017
4	Hypertension (High Blood Pressure) 04/2023 - 10/2013
4	Bradycardia 01/2021 - 12/2005
4	Heart Injuries 01/2019 - 03/2005
3	Obesity 04/2023 - 01/2017
3	Cardiomyopathies (Cardiomyopathy) 01/2019 - 01/2013
3	Diabetes Mellitus 01/2017 - 01/2007
3	Contracture 01/2008 - 04/2001
3	Coronary Disease (Coronary Heart Disease) 01/2007 - 01/2002
2	Myocardial Ischemia (Ischemic Heart Diseases) 11/2017 - 01/2002
2	Atherosclerosis 01/2017 - 09/2002
2	Stomach Ulcer (Gastric Ulcer) 01/2016 - 08/2015
2	Cardiomegaly (Heart Hypertrophy) 05/2015 - 10/2013
2	No-Reflow Phenomenon 01/2014 - 01/2010

Drug/Important Bio-Agent (IBA)

32	Opioid Receptors (Opioid Receptor)IBA 01/2024 - 05/2001
16	Adenosine Triphosphate (ATP)IBA 05/2022 - 09/2001
16	Opioid Analgesics (Opioids)IBA 04/2021 - 02/2000
12	HU 211 (HU 210)IBA 11/2016 - 05/2001
11	D-Penicillamine (2,5)- EnkephalinIBA 03/2021 - 01/2002
10	Ala(2)- deltorphin IIIBA 03/2024 - 11/2005
10	SolutionsIBA 04/2023 - 11/2000
10	Creatine Kinase (Creatine Phosphokinase)IBA 12/2020 - 09/2001
8	CannabinoidsIBA 01/2017 - 05/2001
8	Cannabinoid Receptors (Cannabinoid Receptor)IBA 01/2017 - 06/2001
8	Ala(2)-Arg(6)- enkephalin-LeuIBA 06/2008 - 01/2002
8	delta Opioid Receptors (delta Opioid Receptor)IBA 10/2006 - 09/2000
7	KATP ChannelsIBA 12/2022 - 09/2001
7	kappa Opioid Receptors (kappa Opioid Receptor)IBA 01/2021 - 01/2001
6	Narcotic Antagonists (Opioid Antagonists)IBA 02/2024 - 01/2003
6	ChloraloseIBA 03/2021 - 06/2001
6	LigandsIBA 01/2017 - 03/2000
6	Proteins (Proteins, Gene)FDA Link 01/2013 - 05/2010
5	Peptides (Polypeptides)IBA 01/2024 - 01/2002
5	Naltrexone (ReVia)FDA LinkGeneric 04/2021 - 06/2008
5	mu Opioid Receptors (mu Opioid Receptor)IBA 03/2008 - 04/2001
5	sigma Receptors (sigma Receptor)IBA 03/2004 - 03/2000
4	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 02/2024 - 06/2015
4	naltrindole benzofuranIBA 02/2024 - 06/2016
4	Protein Kinase CIBA 05/2022 - 06/2009
4	tyrosyl- tetrahydroisoquinolinecarbonyl- psi(methylamino)phenylalanyl- phenylalanineIBA 01/2021 - 01/2003
4	Phosphotransferases (Kinase)IBA 12/2020 - 01/2013
4	ORALIT (ORS)IBA 12/2019 - 11/2003
4	Hexamethonium (Hexamethonium Bromide)IBA 07/2017 - 05/2001
4	CB2 Cannabinoid ReceptorIBA 01/2017 - 05/2002
4	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2017 - 08/2011
4	Adenosine (Adenocard)FDA LinkGeneric 01/2016 - 01/2010
3	norbinaltorphimineIBA 02/2024 - 01/2021
3	N-methylnaloxoneIBA 02/2024 - 01/2021
3	LipidsIBA 01/2023 - 01/2002
3	Nitric Oxide Synthase (NO Synthase)IBA 01/2023 - 02/2002
3	Glyburide (Glibenclamide)FDA LinkGeneric 12/2022 - 10/2010
3	(trans)-Isomer 3,4- Dichloro- N- methyl- N- (2- (1- pyrrolidinyl)- cyclohexyl)- benzeneacetamideIBA 04/2021 - 12/2009
3	RimonabantIBA 01/2017 - 05/2001
3	Adrenergic Receptors (Adrenergic Receptor)IBA 05/2016 - 10/2013
3	Ala(2)-MePhe(4)-Gly(5)- Enkephalin (DAGO)IBA 10/2015 - 02/2000
3	CatecholaminesIBA 05/2015 - 04/2003
3	BradykininIBA 01/2015 - 04/2011
3	Erythropoietin FDA Link 01/2013 - 09/2006
3	Nociceptin ReceptorIBA 06/2009 - 11/2004
3	methanandamideIBA 01/2007 - 02/2002
3	anandamide (arachidonylethanolamide)IBA 01/2007 - 02/2002
3	tyrosyl-arginyl-phenylalanyl-lysinamide (DALDA)IBA 11/2003 - 09/2001
3	Thr(6)- Leu(5) Ser(2) enkephalinIBA 07/2003 - 02/2000
2	Neuroprotective AgentsIBA 05/2023 - 01/2016
2	Glucose (Dextrose)FDA LinkGeneric 04/2023 - 01/2017
2	LeptinIBA 01/2023 - 01/2017
2	NG-Nitroarginine Methyl Ester (L-NAME)IBA 01/2023 - 02/2002
2	CorticosteroneIBA 01/2023 - 01/2016
2	5-hydroxydecanoic acidIBA 12/2022 - 05/2017
2	Diazoxide (Hyperstat)FDA Link 12/2022 - 04/2003
2	ICI 199441IBA 01/2021 - 10/2015
2	Protein Kinases (Protein Kinase)IBA 12/2020 - 09/2011
2	Oxygen (Dioxygen)IBA 12/2019 - 01/2002
2	Naloxone (Narcan)FDA LinkGeneric 01/2019 - 06/2016
2	Purinergic P1 Receptors (Adenosine Receptor)IBA 01/2016 - 01/2013
2	Hydrocortisone (Cortisol)FDA LinkGeneric 01/2016 - 08/2015
2	mitochondrial K(ATP) channelIBA 06/2015 - 05/2013
2	Angiotensin IIIBA 05/2015 - 10/2013
2	AldosteroneIBA 05/2015 - 10/2013
2	Endothelins (Endothelin)IBA 05/2015 - 10/2013
2	Thyroid HormonesIBA 05/2015 - 10/2013
2	Purinergic P1 Receptor AgonistsIBA 01/2014 - 01/2010
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2013 - 09/2006

Therapy/Procedure

7	Intravenous Administration 03/2008 - 07/2002
6	Transplantation 01/2016 - 01/2006
5	Ischemic Postconditioning 01/2023 - 01/2012
3	Intravenous Injections 07/2017 - 06/2001
3	Intravenous Infusions 01/2016 - 12/2005
2	Ligation 11/2017 - 11/2005
2	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 01/2016 - 01/2013